Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer

Abstract

Although the use of low-dose aspirin for more than 5 years was associated with decreased risk of lung cancer, particularly among elderly participants and among people without diabetes, the observed effect size was quite modest. Future prospective studies are needed to determine whether there is a causal association.